73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Cencora Inc
Closed
SectorHealthcare
337.29 0.75
Overview
Share price change
24h
Min
334
Max
338.01
Income | -1B -340M |
|---|---|
Sales | 3.1B 84B |
P/E Sector Avg | 45.241 80.03 |
EPS | 3.84 |
Dividend yield | 0.6 |
Profit margin | -0.406 |
Employees | 47,000 |
EBITDA | -1.1B 150M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +17.44% upside |
Dividend yield Sector Avg | 0.60% 2.29% |
|---|
Market Cap | 3.8B 70B |
|---|---|
Previous open | 336.54 |
Previous close | 337.29 |
Cencora Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Cencora Inc Forecast
Price Target
By TipRanks
17.44% upside
12 Months Forecast
Average 393.78 USD 17.44%
High 417 USD
Low 361 USD
Based on 10 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Cencora Inc
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Live chat